Encompass Health (NYSE:EHC – Get Rating) had its price target lowered by analysts at Truist Financial from $75.00 to $65.00 in a research note issued on Monday, The Fly reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 25.77% from the company’s current price.
A number of other equities analysts also recently commented on the stock. Royal Bank of Canada reduced their price objective on shares of Encompass Health from $85.00 to $82.00 in a report on Wednesday, June 8th. TheStreet downgraded shares of Encompass Health from a “b-” rating to a “c+” rating in a report on Tuesday, June 28th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Encompass Health from $80.00 to $62.00 in a report on Wednesday, August 3rd. StockNews.com downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd. Finally, Barclays dropped their target price on shares of Encompass Health from $80.00 to $63.00 and set an “overweight” rating for the company in a research report on Thursday, August 4th. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $71.70.
Encompass Health Price Performance
Shares of Encompass Health stock opened at $51.68 on Monday. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.24 and a quick ratio of 1.24. Encompass Health has a fifty-two week low of $44.33 and a fifty-two week high of $81.45. The firm has a fifty day moving average price of $53.36 and a two-hundred day moving average price of $62.58. The company has a market cap of $5.16 billion, a PE ratio of 15.80, a price-to-earnings-growth ratio of 3.21 and a beta of 0.91.
Encompass Health (NYSE:EHC – Get Rating) last issued its quarterly earnings results on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.97 by ($0.08). The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. Encompass Health’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same period last year, the company earned $1.17 earnings per share. Analysts expect that Encompass Health will post 2.25 EPS for the current year.
Institutional Investors Weigh In On Encompass Health
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Psagot Value Holdings Ltd. Israel increased its position in Encompass Health by 24.4% in the 2nd quarter. Psagot Value Holdings Ltd. Israel now owns 11,200 shares of the company’s stock valued at $628,000 after acquiring an additional 2,200 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its position in Encompass Health by 12.4% in the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 8,996 shares of the company’s stock valued at $504,000 after acquiring an additional 995 shares in the last quarter. SeaCrest Wealth Management LLC acquired a new stake in Encompass Health in the 2nd quarter valued at about $85,000. Lazard Asset Management LLC increased its position in Encompass Health by 2,453.3% in the 2nd quarter. Lazard Asset Management LLC now owns 2,298 shares of the company’s stock valued at $128,000 after acquiring an additional 2,208 shares in the last quarter. Finally, Duality Advisers LP acquired a new stake in Encompass Health in the 2nd quarter valued at about $830,000. Institutional investors and hedge funds own 91.70% of the company’s stock.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Read More
Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
